BBOTVSIMMP• 12 Months (Normalized)
BBOT vs IMMP (BridgeBio Oncology Therapeutics Inc. vs Immutep Limited)
Showing Closing Date Range from Oct 2, 2025 to Oct 2, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BBOT Performance $3.89
-68.73%
BridgeBio Oncology Therapeutics Inc.
Normalized Baseline0.00%
IMMP Performance $4.35
+131.38%
Immutep Limited
Normalized Baseline0.00%
Alpha Spread Margin IMMP LEADS
-200.11 pts
IMMP outperforming by 200.11 percentage points
BBOTIMMP
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BBOT IMMP
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(252 dates)
| Date | BBOT Price | BBOT Gain (%) | IMMP Price | IMMP Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $3.89 | -68.73% | $4.35 | +131.38% | -200.11% |
| Oct 01, 2026 | $- | $4.54 | +141.49% | - | |
| Sep 30, 2026 | $4.10 | -67.04% | $4.65 | +147.34% | -214.38% |
| Sep 29, 2026 | $3.92 | -68.49% | $4.71 | +150.53% | -219.02% |
| Sep 28, 2026 | $3.81 | -69.37% | $- | - | |
| Sep 25, 2026 | $3.95 | -68.25% | $0.26 | -86.17% | +17.92% |
| Sep 24, 2026 | $3.99 | -67.93% | $0.26 | -86.17% | +18.24% |
| Sep 23, 2026 | $4.16 | -66.56% | $0.27 | -85.64% | +19.08% |
| Sep 22, 2026 | $4.66 | -62.54% | $0.28 | -85.11% | +22.57% |
| Sep 21, 2026 | $4.66 | -62.54% | $0.29 | -84.57% | +22.03% |
| Sep 18, 2026 | $4.77 | -61.66% | $0.29 | -84.57% | +22.91% |
| Sep 17, 2026 | $4.89 | -60.69% | $0.32 | -82.98% | +22.29% |
| Sep 16, 2026 | $4.76 | -61.74% | $0.33 | -82.45% | +20.71% |
| Sep 15, 2026 | $4.88 | -60.77% | $0.33 | -82.45% | +21.68% |
| Sep 14, 2026 | $5.05 | -59.41% | $0.33 | -82.45% | +23.04% |
Page 1 of 17